Arrowhead Pharmaceuticals, Inc.'s deal with Sarepta expands its pipeline, but limited plozasiran market and competition ...

A study in weight loss drugs where one third of participants were given a placebo turned out to have some impressive results.

Viking Therapeutics faces tough obesity drug rivals, with VK2735 showing promise but an uncertain edge. Find out why VKTX ...

Despite their benefits, there are a number of things to consider before taking weight loss drugs – including possible ...

The liver is responsible for more than 500 functions in the human body, including filtering harmful substances from the blood ...

The company is preparing a Phase 3 trial of enobosarm with a novel formulation that could extend its patent life.

HHS Secretary Robert F. Kennedy Jr. threatened to bar NIH scientists from publishing in leading medical journals, saying the ...

An international study reveals that the drug can reverse liver damage in patients. An international study led by researchers ...

Doctors are also seeing success in treating people with certain liver diseases. Isaacs prescribes GLP-1s for people with a ...

GLP-1 drugs like Ozempic show widespread promise beyond weight loss/diabetes, but cost and supply limit broader adoption.

Researchers find tirzepatide more effective than semaglutide for weight loss in a 72-week trial, with significant reductions in body weight and waist circumference.

In the wake of early evidence supporting the long-term health benefits of GLP-1 based medications to potentially reduce the ...